SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance

SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance

Bibliographic Details
Main Authors:	Nicola Sgherza, Daniela Di Gennaro, Paola Curci, Rita Rizzi, Daniela Roccotelli, Maria Croce, Martina Avantaggiato, Loredana Ruga, Vanda Strafella, Angelantonio Vitucci, Antonio Palma, Antonella V. Russo Rossi, Teresa Troiano, Angela M. V. Larocca, Maria Chironna, Silvio Tafuri, Francesco Albano, Pellegrino Musto
Format:	Article
Language:	English
Published:	Wiley 2022-12-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000800

Similar Items

P29: EFFECTS OF VACCINATION ON INCIDENCE AND OUTCOME OF SARS-COV-2 INFECTION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
by: N Sgherza, et al.
Published: (2022-04-01)

P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
by: N. Sgherza, et al.
Published: (2022-06-01)

Humoral immune response after anti-SARS-CoV-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)
by: NICOLA SGHERZA, et al.
Published: (2023-01-01)

Scleroderma Associated with Monoclonal Gammopathy of Undetermined Significance
by: Dalya M. M. Abdelmaged, et al.
Published: (2022-12-01)

Monoclonal Gammopathy of Undetermined Significance and Neutrophilic Dermatosis
by: Buthaina Al-Musalhi, et al.
Published: (2016-09-01)

Monoclonal gammopathy of undetermined significance-associated scleromyxoedema
by: Kalgi D Baxi, et al.
Published: (2019-01-01)

Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
by: Nabeel Aslam, MD, et al.
Published: (2021-08-01)

The “Undetermined Significance” of <sup>18</sup>F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
by: Giorgio Treglia, et al.
Published: (2021-08-01)

Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor
by: Nicola Sgherza, et al.
Published: (2021-09-01)

Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients
by: NICOLA SGHERZA, et al.
Published: (2022-06-01)

Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance
by: Aðalbjörg Ýr Sigurbergsdóttir, et al.
Published: (2022-04-01)

Penile Tuberculosis Associated with Monoclonal Gammopathy of Undetermined Significance
by: Wilfred C.H. Wu, et al.
Published: (2006-01-01)

What Is New in the Treatment of Smoldering Multiple Myeloma?
by: Niccolo’ Bolli, et al.
Published: (2021-01-01)

Contributions of the bone microenvironment to monoclonal gammopathy of undetermined significance pathogenesis
by: Gámez, B, et al.
Published: (2018)

Seek and ye shall find: monoclonal gammopathy of undetermined significance
by: Luz Tarín-Arzaga, et al.
Published: (2023-04-01)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
by: Monique A Hartley-Brown, et al.
Published: (2010-02-01)

Monoclonal Gammopathy of Undetermined Cardiovascular Significance; Current Evidence and Novel Insights
by: Anastasios Tentolouris, et al.
Published: (2023-12-01)

Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
by: Oliver C. Lomas, et al.
Published: (2020-06-01)

Identifying monoclonal gammopathy of undetermined significance from electronic health records
by: Hilary C. Tanenbaum, et al.
Published: (2023-03-01)

Xanthogranuloma necrobioticum in the course of monoclonal gammopathy of undetermined significance and idiopathic neutropenia
by: Urszula Maińska, et al.
Published: (2023-04-01)

Geographic Prevalence Patterns and Modifiable Risk Factors for Monoclonal Gammopathy of Undetermined Significance
by: Karina P. Verma, et al.
Published: (2023-11-01)

Immunoglobulin abnormalities and monoclonal gammopathy of undetermined significance in uninfected and HIV-infected men
by: Kyle Robert, et al.
Published: (2010-10-01)

Autoimmune retinopathy associated with monoclonal gammopathy of undetermined significance: a case report
by: Emily A. Eton, et al.
Published: (2020-04-01)

Characterization of monoclonal gammopathy of undetermined significance by calorimetric analysis of blood serum proteome.
by: Francisca Barceló, et al.
Published: (2015-01-01)

Coexistence of Prefibrotic Myelofibrosis with Monoclonal Gammopathy of Undetermined Significance: A Case Report
by: Omar M. Ismail, et al.
Published: (2021-10-01)

Data quality of the monoclonal gammopathy of undetermined significance diagnosis in a hospital registry
by: Gregersen H, et al.
Published: (2013-08-01)

Hypereosinophilia with a pinch of salt and pepper
by: Angelantonio Vitucci, et al.
Published: (2021-08-01)

Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance
by: Alexander J. Ryu, et al.
Published: (2023-02-01)

Monoclonal Gammopathy of Undetermined Significance with Three Bands on Serum Protein Electrophoresis: An Atypical Presentation
by: Rashmi Rasi Datta, et al.
Published: (2023-06-01)

Distinct Nuclear Organization of Telomeres and Centromeres in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
by: Pak Lok Ivan Yu, et al.
Published: (2019-07-01)

Unusual Spherical Bodies in Bone Marrow of a Patient with Monoclonal Gammopathy of Undetermined Significance
by: Habib Moshref Razavi
Published: (2021-06-01)

Predictive Immune Markers for Disease Progression in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
by: İrem Şahver İşgör, et al.
Published: (2022-11-01)

The yin–yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma
by: Zhigang Yi, et al.
Published: (2022-07-01)

Low knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners
by: Charlene M. McShane, et al.
Published: (2019-05-01)

Biclonal gammopathy of undetermined significance in a patient with systemic lupus erythematosus and antiphospholipid syndrome
by: V. Bruzzese, et al.
Published: (2022-02-01)

Intracytoplasmic inclusions in plasma cells: A diagnostic adjunct in monoclonal gammopathy of undetermined significance
by: Smeeta Gajendra, et al.
Published: (2017-01-01)

Noninfectious mixed cryoglobulinaemic glomerulonephritis and monoclonal gammopathy of undetermined significance: a coincidental association?
by: Adam L. Flavell, et al.
Published: (2020-07-01)

Living kidney donor with monoclonal gammopathy of undetermined significance: Is it a contraindication for kidney donation?
by: Vinay Rathore, et al.
Published: (2019-01-01)

Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
by: Daniela Damasceno, et al.
Published: (2021-03-01)

The role of bone marrow microenvironment in the progression of multiple myeloma from monoclonal gammopathy of undetermined significance
by: A. S. Khudovekova, et al.
Published: (2021-09-01)